Lipoprotein Drugs Flashcards

1
Q

Who should be screened for lipids?

A

adults > 20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

LDL cholesterol tx targets

A

CHD/CHD equivalents: LDL <160

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

T/F Non-hdl cholesterol is a better predictor of CHD than ldl-c

A

T –> includes all other cholesterol components/remnants/etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

3 classes of drugs that lower LDL

A
  1. statins -hmg CoA reductase inhibitors
  2. CAI, ezetimibe - cholesterol absorption inhibitors
  3. BAS -bile acid sequestrants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rate limiting step in production of cholesterol

A

hmg coa reductase –> produces mevalonate from acetyl coA –> target of statins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Statins MOA

A

statin appendage mimics HMG CoA and binds reversibly to enzyme thereby inhibiting true substrate (binds w/ higher affinity than substrate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How do statins regulate the LDL receptor?

A

inhibit hmg coa reductase –> reduce cholesterol in liver –> upregulate LDLR to bring more cholesterol in –> suck LDL out of blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

First line tx for ldl reduction

A

statins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Adverse effects of statins

A

elevated hepatic enzymes (modestly and transiently), muscle-related (myalgia, myopathy, rhabdomyolysis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

myalgia

A

muscle ache/weakness w/o CK elevation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

myopathy

A

muscle symptoms w/ elevation in CK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

rhabdomyolysis

A

muscle symptoms with Ck elevation and creatinine elevation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Who is at risk of muscle-related issues with statins

A

frail older women with renal insufficiency, hypothyroidism, polytherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Key molecular mechanism for cholesterol absorption

A

NPC1L1 from lumen into enterocyte

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ezetimibe MOA

A

blocks NPC1L1 and inhibits cholesterol absorption –> reduces cholesterol in liver –> upregulate LDLR –> suck even more cholesterol from blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Adverse effects of Ezetimibe

A

elevated liver enzymes

17
Q

What is IBAT

A

ileal bile acid transporter that recycles bile to the liver from the gut –> reducing bile acid flow via IBAT forces liver to produce more bile acids and shunt cholesterol away from blood

–>cholestyramine, colestipol, colesevelam bind bile acids and end up in feces (safe to use in pregnant women, etc)

18
Q

Adverse effects of BAS

A

bloating, constipation, flatulence, raise TG (via transcriptional effects)

19
Q

ASO to apoB MOA

A

antisense oligonucleotide targets apoB –> reduces VLDL production

20
Q

small molecule MTP inhibitor MOA

A

reduces VLDL by reducing loading of TG to apoB

21
Q

3 classes of drugs that treat TG-HDL axis

A
  1. fibric acid derivatives
  2. omega 3 fatty acids
  3. nicotinic acid
22
Q

Fibric acid derivatives MOA

A

e.g. phenofibrate –> activate PPARalpha (nuclear receptor) –> increased HDL production, reduced VLDL production, increased VLDL clearance (via a lot of different pathways)

23
Q

Adverse effects of fibrates

A

myalgias, liver enzymes, but otherwise well tolerated

24
Q

Omega 3 MOA

A

EPA and DHA –> reduce TG and raise HDL (for preventing pancreatitis but not clear evidence on cv risk)

25
nicotinic acid MOA
niacin/vitamin B3 --> blocks adipose lipolysis --> reduce FFA --> reduce liver flux --> reduce VLDL production *increases HDL, reduces TG, reduces LDL, reduces Lp(a)
26
Adverse effects of niacin
flushing, hyperuricemia, hepatotoxicitiy, contraindicated in insulin resistance
27
CETP inhibitors MOA
inhibits transfer of cholesterol out of HDL into LDL --> huge elevation in HDL and reduction of LDL